There is no product in the shopping cart, buy it!
| Size | Qty | Add To Basket |
|---|---|---|
| 1 mg | ||
| 2 mg | ||
| 5 mg |
| Product Overview | Recombinant Human IGFBP4 protein (NP_001543.2) is produced in Glycoengineered Human Cell Line. This expression system is used for the production of glycoproteins and antibodies with human post-translational modifications. |
| Source | Glycoengineered Human Cell Lines |
| Species | Human |
| Tag | His-Tag, FC-Tag or other Tags as required. |
| Purity | >90% |
| Endotoxin Level | Regular batch |
| Conjugation | None |
| Target | IGFBP4 |
| Full Name | Insulin-like growth factor-binding protein 4 |
| Gene ID | 3487 |
| Uniprot ID | P22692 |
| Accession Number | NP_001543.2 |
| Background | This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma in both glycosylated and non-glycosylated forms. |
| Alternate Names | BP-4; IBP4; IGFBP-4; HT29-IGFBP |